TY - JOUR
T1 - Expression of Metallothionein in Node‐Negative Breast Cancer Correlates with Poor Prognosis
AU - Nadji, Mehrdad
AU - Nassiri, Mehdi
AU - Fresno, Manuel
AU - Herrero, Agustiin
AU - Morales, Azorides R.
PY - 1995/11
Y1 - 1995/11
N2 - Abstract: Metallothionein (MT) is a cysteine‐rich protein that binds metals and is present in a number of normal cells, mainly during fetal life. It has been suggested that the developmental profile of metallothionein is similar to oncofetal gene products, and therefore, it could be potentially used as a prognostic tumor marker. We explored this concept by performing immuno‐histochemical stain for metallothionein in 155 axillary lymph node‐negative breast carcinomas. Traditional tumor prognosticators of breast cancer including histologic type, nuclear grade, and estrogen receptor content were also analyzed to determine whether or not metallothionein is an independent marker of behavior. Moderate to strong metallothionein immunoreactivity of tumor cells correlated with decreased disease free (p < 0.02), and overall survivals (p < 0.03). No correlation was found between MT and histologic type and nuclear grade of tumors. Similarly, there was no statistically significant relationship between MT and estrogen receptor contents. It is concluded that overexpression of metallothionein is an independent indicator of poor prognosis in node‐negative breast carcinomas.
AB - Abstract: Metallothionein (MT) is a cysteine‐rich protein that binds metals and is present in a number of normal cells, mainly during fetal life. It has been suggested that the developmental profile of metallothionein is similar to oncofetal gene products, and therefore, it could be potentially used as a prognostic tumor marker. We explored this concept by performing immuno‐histochemical stain for metallothionein in 155 axillary lymph node‐negative breast carcinomas. Traditional tumor prognosticators of breast cancer including histologic type, nuclear grade, and estrogen receptor content were also analyzed to determine whether or not metallothionein is an independent marker of behavior. Moderate to strong metallothionein immunoreactivity of tumor cells correlated with decreased disease free (p < 0.02), and overall survivals (p < 0.03). No correlation was found between MT and histologic type and nuclear grade of tumors. Similarly, there was no statistically significant relationship between MT and estrogen receptor contents. It is concluded that overexpression of metallothionein is an independent indicator of poor prognosis in node‐negative breast carcinomas.
UR - http://www.scopus.com/inward/record.url?scp=0029177677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029177677&partnerID=8YFLogxK
U2 - 10.1111/j.1524-4741.1995.tb00264.x
DO - 10.1111/j.1524-4741.1995.tb00264.x
M3 - Article
AN - SCOPUS:0029177677
VL - 1
SP - 372
EP - 375
JO - Breast Journal
JF - Breast Journal
SN - 1075-122X
IS - 6
ER -